SEC Form 4 · accession 0001209191-16-138295
Dare Bioscience, Inc. · DARE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alejandra Carvajal
Officer — VP, General Counsel
Period of report
Aug 22, 2016
Accepted (ET)
Aug 23, 2016 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401914
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock (right to buy)F1 | $1.14 | Aug 22, 2016 | A | 75,000 | A | — | Aug 21, 2026 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1This option was granted on August 22, 2016. The option is scheduled to vest as to 25% of the shares on the six-month anniversary of August 22, 2016 and as to an additional 25% of the original number of shares at the end of each six-month period of continuous service thereafter until August 22, 2018.